We found that NR4A1 suppressed tumor growth in BC by antagonizing the c-Fos-mediated transcriptional activation of PRDX6, a bifunctional enzyme involved in cellular lipid and redox homeostasis. This evidence concerns the gene FOS and breast cancer.